Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024 08:00 ET
|
Checkpoint Therapeutics, Inc
WALTHAM, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that...
Avenue Therapeutics to Participate in Upcoming Investor Conferences
September 03, 2024 08:30 ET
|
Avenue Therapeutics
MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of...